Literature DB >> 16021270

Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study.

Nelson Hamerschlak1, Eliane Maluf, Ricardo Pasquini, José Eluf-Neto, Frederico Rafael Moreira, Alexandre Biasi Cavalcanti, Iria Ruriko Okano, Roberto Passeto Falcão, Marimília Teixeira Pita, Sandra Regina Loggetto, Luiz Gastão Rosenfeld, Irene Gyongyvér Heidemarie Lorand-Metze.   

Abstract

CONTEXT AND
OBJECTIVE: Aplastic anemia and agranulocytosis are rare but life-threatening disorders, often caused by drugs and other environmental exposures. Reported incidence of these diseases seems to vary between different geographic regions, and few data on their incidence are available for Latin American countries. The aim of this work is to determine the incidence of agranulocytosis and aplastic anemia in Brazil. DESIGN AND
SETTING: Incidence study. Seven centers took part in the pilot phase, so as to represent all Brazilian regions.
METHODS: Each center conducted an active search for new cases in a defined region by means of regular contacts with all hematologists, main clinical laboratories and clinicians in hospitals of the region.
RESULTS: 74 patients with aplastic anemia and 16 with agranulocytosis were identified. Patients with agranulocytosis had a median age of 31 years (interquartile range, IQR: 12.5-48.2); 32.2% were male and 81.2% were white. The median age of aplastic anemia patients was 21 years (IQR 15.0-35.2); 62.2% were male, 50.0% were white and 39.2% mulatto. The incidence of agranulocytosis was estimated to be 0.5 cases per million individuals per year, ranging from 0.0 to 1.1 cases per million per year between regions. The incidence of aplastic anemia was 2.7 cases per million per year, ranging from 1.1 to 7.1 cases per million per year between regions.
CONCLUSIONS: Aplastic anemia and agranulocytosis are rare diseases in Brazil. However, there is considerable variability in their incidences between different regions.

Entities:  

Mesh:

Year:  2005        PMID: 16021270     DOI: 10.1590/s1516-31802005000300002

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  8 in total

1.  Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.

Authors:  Eliane Maluf; Nelson Hamerschlak; Alexandre Biasi Cavalcanti; Alvaro Avezum Júnior; José Eluf-Neto; Roberto Passetto Falcão; Irene G Lorand-Metze; Daniel Goldenberg; Cézar Leite Santana; Daniela de Oliveira Werneck Rodrigues; Leny Nascimento da Motta Passos; Luis Gastão Mange Rosenfeld; Marimilia Pitta; Sandra Loggetto; Andreza A Feitosa Ribeiro; Elvira Deolinda Velloso; Andrea Tiemi Kondo; Erika Oliveira de Miranda Coelho; Maria Carolina Tostes Pintão; Hélio Moraes de Souza; José Rafael Borbolla; Ricardo Pasquini
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 2.  WITHDRAWN: Dipyrone for acute primary headaches.

Authors:  Adriana S Ramacciotti; Bernardo G O Soares; Alvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2014-07-11

3.  Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Authors:  Têmis Maria Félix; Bibiana Mello de Oliveira; Milena Artifon; Isabelle Carvalho; Filipe Andrade Bernardi; Ida V D Schwartz; Jonas A Saute; Victor E F Ferraz; Angelina X Acosta; Ney Boa Sorte; Domingos Alves
Journal:  Orphanet J Rare Dis       Date:  2022-02-24       Impact factor: 4.123

4.  Incidence and risk factors for agranulocytosis in Latin American countries--the Latin Study: a multicenter study.

Authors:  Nelson Hamerschlak; Eliane Maluf; Alexandre Biasi Cavalcanti; Alvaro Avezum Júnior; José Eluf-Neto; Roberto Passeto Falcão; Irene Gyongyvér Heidemarie Lorand-Metze; Daniel Goldenberg; Cézar Leite Santana; Daniela de Oliveira Werneck Rodrigues; Leny Nascimento da Motta Passos; Erika Oliveira de Miranda Coelho; Maria Carolina Tostes Pintão; Hélio Moraes de Souza; José Rafael Borbolla; Ricardo Pasquini
Journal:  Eur J Clin Pharmacol       Date:  2008-06-26       Impact factor: 2.953

Review 5.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

6.  Human embryonic stem cell therapy for aplastic anemia.

Authors:  Geeta Shroff; Rakesh Gupta; Lalduhawmi Zadeng
Journal:  Clin Case Rep       Date:  2017-04-26

7.  Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.

Authors:  Ting Wang; Shu-chong Mei; Rong Fu; Hua-quan Wang; Zong-hong Shao
Journal:  J Immunol Res       Date:  2014-05-06       Impact factor: 4.493

8.  Metamizole versus ibuprofen at home after day surgery: study protocol for a randomised controlled trial.

Authors:  Björn Stessel; Michiel Boon; Elbert A Joosten; Jean-Paul Ory; Stefan Evers; Sander M J van Kuijk; Jasperina Dubois; Daisy Hoofwijk; Luc Jamaer; Wolfgang F F A Buhre
Journal:  Trials       Date:  2016-09-26       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.